T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Community Health Systems
CYH
$419M
| $329K | ﹤0.01% |
109,987
+9,300
| +9% | +$39.1K |
|
2452
Krispy Kreme
DNUT
$569M
| $329K | ﹤0.01% |
33,087
+5,032
| +18% | +$54.5K |
|
2453
Amplitude
AMPL
$1.66B
| $328K | ﹤0.01% |
31,045
+6,046
| +24% | +$60.5K |
|
2454
First Mid Bancshares
FMBH
$1.39B
| $328K | ﹤0.01% |
8,884
+1,389
| +19% | +$55.2K |
|
2455
Bristow Group
VTOL
$1.38B
| $328K | ﹤0.01% |
9,561
+1,502
| +19% | +$53K |
|
2456
World Acceptance Corp
WRLD
$875M
| $328K | ﹤0.01% |
2,909
+535
| +23% | +$62.4K |
|
|
SEG
2457
Seaport Entertainment Group
SEG
$366M
| $327K | ﹤0.01% |
11,684
+4,399
| +60% | +$127K |
|
|
HOUS
2458
DELISTED
Anywhere Real Estate
HOUS
| $326K | ﹤0.01% |
98,659
+6,192
| +7% | +$26.5K |
|
2459
Northrim BanCorp
NRIM
$601M
| $326K | ﹤0.01% |
16,724
+172
| +1% | +$3.29K |
|
2460
PDF Solutions
PDFS
$2.13B
| $326K | ﹤0.01% |
12,025
+1,756
| +17% | +$52.9K |
|
2461
American Vanguard Corp
AVD
$62.8M
| $324K | ﹤0.01% |
69,909
+2,221
| +3% | +$12K |
|
|
NOVA
2462
DELISTED
Sunnova Energy
NOVA
| $324K | ﹤0.01% |
94,394
+8,172
| +9% | +$40.9K |
|
2463
ProPetro Holding
PUMP
$1.42B
| $324K | ﹤0.01% |
34,702
+4,996
| +17% | +$41.1K |
|
2464
Amerant Bancorp
AMTB
$1.14B
| $323K | ﹤0.01% |
14,377
+4,767
| +50% | +$108K |
|
2465
Arcturus Therapeutics
ARCT
$223M
| $323K | ﹤0.01% |
19,018
+1,279
| +7% | +$24.1K |
|
2466
DocGo
DCGO
$64.5M
| $322K | ﹤0.01% |
75,872
+18,844
| +33% | +$72.6K |
|
2467
D-Wave Quantum Inc. Common Stock
QBTS
$7.78B
| $322K | ﹤0.01% |
38,270
+9,856
| +35% | +$29.5K |
|
2468
Microvast
MVST
$341M
| $320K | ﹤0.01% |
154,200
| – | – |
|
|
OLO
2469
DELISTED
Olo Inc
OLO
| $320K | ﹤0.01% |
41,634
-10,631
| -20% | -$66.4K |
|
2470
ZipRecruiter
ZIP
$388M
| $320K | ﹤0.01% |
44,060
-113,661
| -72% | -$1.02M |
|
2471
Hyliion Holdings
HYLN
$734M
| $318K | ﹤0.01% |
121,536
+12,007
| +11% | +$33.4K |
|
2472
Standard BioTools
LAB
$294M
| $318K | ﹤0.01% |
181,468
+16,475
| +10% | +$30.7K |
|
2473
Zymeworks
ZYME
$1.83B
| $316K | ﹤0.01% |
21,583
+3,235
| +18% | +$45.2K |
|
|
RVNC
2474
DELISTED
Revance Therapeutics, Inc.
RVNC
| $316K | ﹤0.01% |
103,915
+7,839
| +8% | +$34.1K |
|
|
DEC
2475
Diversified Energy Company
DEC
$1B
| $315K | ﹤0.01% |
18,744
+3,513
| +23% | +$49.1K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.